Stenotrophomonas maltophilia infections

被引:29
作者
Dignani, MC
Grazziutti, M
Anaissie, E
机构
[1] Univ Arkansas Med Sci, Arkansas Canc Res Ctr, Myeloma Inst Res & Treatment, Little Rock, AR 72205 USA
[2] FUNDALEU, Buenos Aires, DF, Argentina
[3] FUNCEI, Buenos Aires, DF, Argentina
关键词
Stenotrophomonas maltophilia; nosoconnial infections; immunocompromised host;
D O I
10.1055/s-2003-37920
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Stenotrophomonas maltophilia is a ubiquitous, gram-negative organism that causes hospital-acquired infections. Persons often come in contact with S. maltophilia through environmental water sources, including hospital tap water or faucets, and it has been associated with nosocomial outbreaks of infection. S. maltophilia often infects debilitated persons and those with underlying medical conditions, including immunosuppression. Manifestations of infection include pneumonia, often in mechanically ventilated patients, bacteremia, skin and soft tissue infection, urinary tract infection, and endocarditis. Treatment of S. mallophilia infection is difficult because the organism is resistant to a number of agents typically used for hospital-acquired infections. In vitro and clinical data indicate that trimethoprim-sulfamethoxazole is the agent of choice. Beta-lactamase inhibitors such as clavulanate are also active, and combination therapy may be indicated for certain serious infections due to S. maltophilia.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 141 条
[1]   Xanthomonas maltophilia infection in chronic peritoneal dialysis patients [J].
Al-Hilali, N ;
Nampoory, MRN ;
Johny, KV ;
Chugh, TD .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2000, 34 (01) :67-69
[2]   Two consecutive outbreaks of Stenotrophomonas maltophilia (Xanthomonas maltophilia) in an intensive-care unit defined by restriction fragment-length polymorphism typing [J].
Alfieri, N ;
Ramotar, K ;
Armstrong, P ;
Spornitz, ME ;
Ross, G ;
Winnick, J ;
Cook, DR .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (08) :553-556
[3]   In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates - Comparison of the agar dilution method with the E-test and two agar diffusion methods [J].
Arpi, M ;
Victor, MA ;
Mortensen, I ;
Gottschau, A ;
Bruun, B .
APMIS, 1996, 104 (02) :108-114
[4]  
Aydin K, 2000, SCAND J INFECT DIS, V32, P427, DOI 10.1080/003655400750045060
[5]   STENOTROPHOMONAS MALTOPHILIA IN CYSTIC-FIBROSIS PATIENTS [J].
BALLESTERO, S ;
VIRSEDA, I ;
ESCOBAR, H ;
SUAREZ, L ;
BAQUERO, F .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (08) :728-729
[6]  
Belzunegui J, 2000, CLIN EXP RHEUMATOL, V18, P265
[7]  
Benian Ö, 2002, OPHTHALMIC SURG LAS, V33, P253
[8]  
BERBARI N, 1993, HEART LUNG, V22, P282
[9]  
Bland L A, 1989, ASAIO Trans, V35, P314, DOI 10.1097/00002480-198907000-00044
[10]   Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates [J].
Bonfiglio, G ;
Cascone, C ;
Azzarelli, C ;
Cafiso, V ;
Marchetti, F ;
Stefani, S .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (01) :115-117